title: Splenic abscess in cancer chemotherapy.
abstract: BACKGROUND
  Splenic abcess is an uncommon complication for cancer treatment. It occurs more frequently in immunocompromised patients. They are characterized by high mortality. The classic triad (fever, pain of the left hypochondrium, and sensitive mass left) is only present in one-third of cases the clinical spectrum ranging from no symptoms to events such as fever, nausea, vomiting, weight loss, abdominal pain left, splenomegaly. Treatment options are limited, but must be discussed and adapted to the patient profile.
  
  
  METHODS
  We report the case of a 62-year-old Arabic male, diagnosed with metastatic lung adenocarcinoma, who, after several cycles of chemotherapy, presented symptoms and signs of splenic abcess.
  
  
  CONCLUSIONS
  Splenic abcess is rare situation, which must be actively researched, to have access to an optimal therapeutic approach.
authors.affiliation: Medical Oncology Unit, IBN SINA Military Hospital, Marrakesh, Morocco. ismail_onco@yahoo.fr.
authors.forename: Essadi
authors.initials: E
authors.lastname: Ismail
authors.affiliation: General Surgery Unit, IBN SINA Military Hospital, Marrakesh, Morocco. relbarni@gmail.com.
authors.forename: Rachid
authors.initials: R
authors.lastname: El Barni
authors.affiliation: General Surgery Unit, IBN SINA Military Hospital, Marrakesh, Morocco. medlahkim@yahoo.fr.
authors.forename: Mohamed
authors.initials: M
authors.lastname: Lahkim
authors.affiliation: Radiology Unit, IBN SINA Military Hospital, Marrakesh, Morocco. redrokhsi@yahoo.fr.
authors.forename: Redouane
authors.initials: R
authors.lastname: Rokhsi
authors.affiliation: Radiology Unit, IBN SINA Military Hospital, Marrakesh, Morocco. atelmehdi@yahoo.fr.
authors.forename: Elmehdi
authors.initials: E
authors.lastname: Atmane
authors.affiliation: Radiology Unit, IBN SINA Military Hospital, Marrakesh, Morocco. abdelghanielf@gmail.com.
authors.forename: Abdelghani
authors.initials: A
authors.lastname: El Fikri
authors.affiliation: General Surgery Unit, IBN SINA Military Hospital, Marrakesh, Morocco. bouchrachid@gmail.com.
authors.forename: Rachid
authors.initials: R
authors.lastname: Bouchama
authors.affiliation: General Surgery Unit, IBN SINA Military Hospital, Marrakesh, Morocco. abdesachour@gmail.com.
authors.forename: Abdessamad
authors.initials: A
authors.lastname: Achour
authors.affiliation: Internal Medicine Unit, IBN SINA Military Hospital, Marrakesh, Morocco. medzyani@gamil.com.
authors.forename: Mohamed
authors.initials: M
authors.lastname: Zyani
mesh_terms: D000038:Abscess / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D050256:Antimitotic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013156:Splenectomy; D013158:Splenic Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D013163:Splenomegaly; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D050256:Antimitotic Agents